About Index Trending news
Analyze
Pricing
Celgene Corporation

Celgene Corporation

Work at Celgene Corporation? Add yourself to this profile

Celgene Corporation

Global biopharmaceutical company. Tweets by Greg Geissman & Julissa Viana. Review our guidelines on our site

Elsewhere

Alexa global traffic share

Twitter followers

29 Nov 2016
Undisclosed funding
Added by

Celgene Invests More in GNS Healthcare For Machine Learning Software

Xconomy
01 Sep 2016
$70,000,000
Venture capital (Series B)
Celgene, Foresite Capital, Invus, +6
Added by

Arcus Biosciences Raises $70M in Series B Funding

FinSMEs
08 Aug 2016
$37,000,000
Venture capital (Series B)

Startup targeting protein degradation in cancer raises $37M

MedCity News
+3
19 Jul 2016
$57,000,000
Venture capital (Series A)
Added by
12 Jul 2016
$22,500,000
Venture capital (Series A)
Celgene, Eshelman Ventures, Healthlink Capital, +1

New York Startup Sapience Therapeutics Nabs 22 5 Million Series A Financing

biospace
+1
17 May 2016

Agenovir Raises $10.6M in Series A Financing

FinSMEs
+2
04 May 2016
$46,000,000
Venture capital (Series A)
Added by
26 Apr 2016
$50,000,000
Venture capital (Series B)
Kleiner Perkins Caufield & Byers, Celgene, Topspin Partners, +1

Venture Capital Access Online | Venture Capital News

vcaonline
+1
05 Apr 2016
$220,000,000
Venture capital (Series B)

Venter's Human Longevity raises $220M with help from Celgene, Illumina

FierceBiotech
+1
04 Apr 2016
$220,000,000
Venture capital (Series B)
Added by

Human Longevity Raises over $220M in Series B Funding

FinSMEs
08 Jan 2016
$61,500,000
Venture capital (Series A)
Added by

Zymeworks snags huge $61.5 million Series A round

BetaKit
+2
30 Apr 2015
$41,800,000
Venture capital (Series D)
Added by

Mirna Therapeutics Secures $41.8 Million Series D Financing to Advance Oncology MicroRNA Pipeline

Marketwire
28 Apr 2015
$64,000,000
Venture capital (Series B)
Added by

As patent battle brews, Celgene and GSK lead $64M raise for CRISPR Therapeutics

FierceBiotech
17 Dec 2014
$38,000,000
Venture capital (Series B)
Added by

Celgene Backed Startup Flexus Biosciences Secures 38 Million

biospace
+1
20 Oct 2014
Venture capital
Added by

Celgene Participates in New Round of Investment for Sequenta

businesswire
23 Sep 2014
$50,600,000
Venture capital (Series B)
Added by

SEC FORM D/A

sec
10 Jun 2014
$25,000,000
Private equity
Added by

CELGENE MAKES LANDMARK INVESTMENT IN NANTHEALTH TO ADVANCE GROUNDBREAKING CANCER RESEARCH FOR PATIENTS

NANTHEALTH